Trials / Unknown
UnknownNCT00730860
Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE
Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation Associated With Postoperative Transhepatic Arterial Chemoembolization--a Prospective Randomized Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Southwest Hospital, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A RCT was conducted to elucidate whether the treatment outcome of HCC could be improved by RFA associated with postoperative TACE.
Detailed description
A randomized study was conducted to elucidate whether the outcome of hepatocellular carcinoma could be improved by radiofrequency ablation associated with postoperative transhepatic arterial chemoembolization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | radiofrequency ablation associated with TACE | treatment of hepatocellular carcinoma by radiofrequency ablation associated with postoperative transhepatic arterial chemoembolization |
| PROCEDURE | radiofrequency ablation only | treatment of hepatocellular carcinoma by radiofrequency ablation only |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2018-01-30
- Completion
- 2018-06-01
- First posted
- 2008-08-08
- Last updated
- 2017-03-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00730860. Inclusion in this directory is not an endorsement.